Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXL3IC
|
||||
| Drug Name |
2-(4-chloro-6-(3-chlorophenylamino)pyrimidin-2-ylthio)-2-(naphthalen-1-yl)acetic acid
|
||||
| Synonyms |
CHEMBL1089467
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H15Cl2N3O2S
|
||||
| Canonical SMILES |
OC(=O)C(Sc1nc(Cl)cc(Nc2cccc(Cl)c2)n1)c3cccc4ccccc34
|
||||
| InChI |
InChI=1S/C22H15Cl2N3O2S/c23-14-7-4-8-15(11-14)25-19-12-18(24)26-22(27-19)30-20(21(28)29)17-10-3-6-13-5-1-2-9-16(13)17/h1-12,20H,(H,28,29)(H,25,26,27)
|
||||
| InChIKey |
HVMQERGLUKDWRN-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | [1587926] | ||
| Arachidonate 5-lipoxygenase | Target Info | [1587926] | |||
| PANTHER Pathway | CCKR signaling map ST | ||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| WikiPathways | Wnt Signaling Pathway Netpath | ||||
| Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| Differentiation of white and brown adipocyte | |||||
| Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
| Transcriptional Regulation of White Adipocyte Differentiation | |||||
| Adipogenesis | |||||
| SREBP signalling | |||||
| Nuclear ReceptorsWP2877:Vitamin D Receptor Pathway | |||||
| Arachidonic acid metabolism | |||||
| Eicosanoid Synthesis | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.